Evidence map›Paper›PMID 39345444›Full record

ArticlebioRxiv : the preprint server for biology2024

Integrative multiomic approaches reveal ZMAT3 and p21 as conserved hubs in the p53 tumor suppression network.

Anthony M Boutelle, Aicha R Mabene, David Yao, Haiqing Xu, Mengxiong Wang, Yuning J Tang, Steven S Lopez, Sauradeep Sinha, Janos Demeter, Ran Cheng and 11 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Anthony M Boutelle
Aicha R Mabene
David Yao
Haiqing Xu
Mengxiong Wang
Yuning J Tang
Steven S Lopez
Sauradeep Sinha
Janos Demeter
Ran Cheng
Brooks A Benard
Liz J Valente
Alexandros P Drainas
Ravindra Majeti
Dmitri A Petrov
Peter K Jackson
Fan Yang
Monte M Winslow
Michael C Bassik
Laura D Attardi

Funding

Leveraging innovative technologies in basic and clinical cancer researchT32CA009302 · NCI · STANFORD UNIVERSITY · PI LAURA D ATTARDI, Aaron M Newman · 1985 to 2026
$19.1M
NCI NIH HHS T32 CA009302
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39345444
PMCPMC11429870

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.